Effect of prolyl hydroxylase domain-2 haplodeficiency on the hepatocarcinogenesis in mice

Femke Heindryckx; Anna Kuchnio; Christophe Casteleyn; Stéphanie Coulon; Kim Olievier; Isabelle Colle; Anja Geerts; Louis Libbrecht; Peter Carmeliet; Hans Van Vlierberghe

doi:10.1016/j.jhep.2012.02.021

Related publications

Article2016

Effect of prolyl hydroxylase domain 2 haplodeficiency on liver progenitor cell characteristics in early mouse hepatocarcinogenesis

Eliene Bogaerts, Annelies Paridaens, Xavier Verhelst, Peter Carmeliet, Anja Geerts, Hans Van Vlierberghe, Lindsey Devisscher

Article2012

Emerging novel functions of the oxygen-sensing prolyl hydroxylase domain enzymes

Brian W. Wong, Anna Kuchnio, Ulrike Brüning, Peter Carmeliet

Article2009

Loss or Silencing of the PHD1 Prolyl Hydroxylase Protects Livers of Mice Against Ischemia/Reperfusion Injury

Martin Schneider, Katie Van Geyte, Peter Fraisl, Judit Kiss, Julián Aragonés, Massimiliano Mazzone, Heimo Mairbäurl, Katrien De Bock, Nam Ho Jeoung, Martin Mollenhauer, Μαρία Γεωργιάδου, Tammie Bishop, Carmen Roncal, Andrew Sutherland, Bénédicte F. Jordan, Bernard Gallez, Jürgen Weitz, Robert A. Harris, Patrick H. Maxwell, Myriam Baes, Peter J. Ratcliffe, Peter Carmeliet

Article2011

Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice

Sarah R. Walmsley, Edwin R. Chilvers, A. A. Roger Thompson, Kathryn Vaughan, Helen M. Marriott, Lisa C. Parker, Gary S. Shaw, Selina Parmar, Martin Schneider, Ian Sabroe, David H. Dockrell, Marta Milo, Cormac T. Taylor, Randall S. Johnson, Christopher W. Pugh, Peter J. Ratcliffe, Patrick H. Maxwell, Peter Carmeliet, Moira K. B. Whyte

Article2021

Whole-Body Prolyl Hydroxylase Domain (PHD) 3 Deficiency Increased Plasma Lipids and Hematocrit Without Impacting Plaque Size in Low-Density Lipoprotein Receptor Knockout Mice

Jasper A. F. Demandt, Kim van Kuijk, Thomas Theelen, Elke Marsch, Sean Heffron, Edward A. Fisher, Peter Carmeliet, Erik A.L. Biessen, Judith C. Sluimer